136 related articles for article (PubMed ID: 1933810)
1. The prognostic significance of ploidy analysis in operable breast cancer.
Sharma S; Mishra MC; Kapur BM; Verma K; Nath I
Cancer; 1991 Dec; 68(12):2612-6. PubMed ID: 1933810
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of flow cytometric DNA analysis in node-negative breast cancer patients.
Lewis WE
Cancer; 1990 May; 65(10):2315-20. PubMed ID: 2346915
[TBL] [Abstract][Full Text] [Related]
3. DNA ploidy and percent S-phase as prognostic factors in node-positive breast cancer: results from patients enrolled in two prospective randomized trials.
Witzig TE; Ingle JN; Schaid DJ; Wold LE; Barlow JF; Gonchoroff NJ; Gerstner JB; Krook JE; Grant CS; Katzmann JA
J Clin Oncol; 1993 Feb; 11(2):351-9. PubMed ID: 8426213
[TBL] [Abstract][Full Text] [Related]
4. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
Pinto AE; André S; Soares J
J Clin Pathol; 1999 Aug; 52(8):604-11. PubMed ID: 10645231
[TBL] [Abstract][Full Text] [Related]
5. The prognostic significance of nuclear DNA content in invasive breast cancer--a study with long-term follow-up.
Toikkanen S; Joensuu H; Klemi P
Br J Cancer; 1989 Nov; 60(5):693-700. PubMed ID: 2553094
[TBL] [Abstract][Full Text] [Related]
6. Tumour DNA ploidy as an independent prognostic factor in breast cancer.
Kallioniemi OP; Blanco G; Alavaikko M; Hietanen T; Mattila J; Lauslahti K; Koivula T
Br J Cancer; 1987 Nov; 56(5):637-42. PubMed ID: 3426929
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of DNA-ploidy in a series of 690 primary breast cancer patients.
Beerman H; Kluin PM; Hermans J; van de Velde CJ; Cornelisse CJ
Int J Cancer; 1990 Jan; 45(1):34-9. PubMed ID: 2298504
[TBL] [Abstract][Full Text] [Related]
8. Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features.
Gasparini G; Gullick WJ; Bevilacqua P; Sainsbury JR; Meli S; Boracchi P; Testolin A; La Malfa G; Pozza F
J Clin Oncol; 1992 May; 10(5):686-95. PubMed ID: 1349034
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric DNA ploidy defines patients with poor prognosis in node-negative breast cancer.
Balslev I; Christensen IJ; Rasmussen BB; Larsen JK; Lykkesfeldt AE; Thorpe SM; Rose C; Briand P; Mouridsen HT
Int J Cancer; 1994 Jan; 56(1):16-25. PubMed ID: 8262673
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient.
Haffty BG; Toth M; Flynn S; Fischer D; Carter D
J Clin Oncol; 1992 Dec; 10(12):1839-47. PubMed ID: 1453198
[TBL] [Abstract][Full Text] [Related]
11. DNA index and S-phase fraction and their combination as prognostic factors in operable ductal breast carcinoma.
Joensuu H; Toikkanen S; Klemi PJ
Cancer; 1990 Jul; 66(2):331-40. PubMed ID: 2164437
[TBL] [Abstract][Full Text] [Related]
12. DNA content flow cytometry as a prognostic factor for node-positive breast cancer. The role of multiparameter ploidy analysis and specimen sonication.
Witzig TE; Gonchoroff NJ; Therneau T; Gilbertson DT; Wold LE; Grant C; Grande J; Katzmann JA; Ahmann DL; Ingle JN
Cancer; 1991 Oct; 68(8):1781-8. PubMed ID: 1913523
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of DNA ploidy in breast cancer stage I-II.
Cufer T; Lamovec J; Bracko M; Lindtner J; Us-Krasovec M
Neoplasma; 1997; 44(2):127-32. PubMed ID: 9201293
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric analysis of DNA ploidy in primary, metastatic and recurrent breast cancers.
Tsutsui S; Ohno S; Murakami S; Kataoka A; Kinoshita J; Hachitanda Y
Oncol Rep; 2002; 9(4):793-9. PubMed ID: 12066211
[TBL] [Abstract][Full Text] [Related]
15. Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer.
Baak JP; Chin D; van Diest PJ; Ortiz R; Matze-Cok P; Bacus SS
Lab Invest; 1991 Feb; 64(2):215-23. PubMed ID: 1671789
[TBL] [Abstract][Full Text] [Related]
16. Mammographic growth rate, DNA ploidy, and S-phase fraction analysis in breast carcinoma. A prognostic evaluation in a screened population.
Arnerlöv C; Emdin SO; Lundgren B; Roos G; Söderström J; Bjersing L; Norberg C; Angquist KA
Cancer; 1992 Oct; 70(7):1935-42. PubMed ID: 1525769
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of DNA ploidy determined by high-resolution flow cytometry in breast carcinoma.
Bracko M; Us-Krasovec M; Cufer T; Lamovec J; Zidar A; Goehde W
Anal Quant Cytol Histol; 2001 Feb; 23(1):56-66. PubMed ID: 11233744
[TBL] [Abstract][Full Text] [Related]
18. DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S-phase fraction to outcome of patients in NSABP B-04.
Fisher B; Gunduz N; Costantino J; Fisher ER; Redmond C; Mamounas EP; Siderits R
Cancer; 1991 Oct; 68(7):1465-75. PubMed ID: 1893345
[TBL] [Abstract][Full Text] [Related]
19. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
[TBL] [Abstract][Full Text] [Related]
20. DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma.
Bosari S; Lee AK; Tahan SR; Figoni MA; Wiley BD; Heatley GJ; Silverman ML
Cancer; 1992 Oct; 70(7):1943-50. PubMed ID: 1525770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]